Form 4 for MCD McDonald's
Accepted 2026-02-17 00:00:00 ET · period of report 2026-02-12 · accession 0001598115-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-02-17 | 2026-02-12+ | MCD | Kempczinski Christopher J | COB, CEO, Dir | S - Sale+OE | $332.44 | -52.6K | 22.9K | -70% | -$17.47M |
| DT | 2026-02-17 | 2026-02-13 | MCD | Kempczinski Christopher J | COB, CEO, Dir | F - Tax | $327.58 | -9,182 | 34.4K | -21% | -$3.01M |
| DMT | 2026-02-17 | 2026-02-12+ | MCD | Kempczinski Christopher J | COB, CEO, Dir | M - OptEx | $91.86 | +73.3K | 49.2K | New | +$6.73M |
| DMT | 2026-02-17 | 2026-02-12+ | MCD | Kempczinski Christopher J | COB, CEO, Dir | M - OptEx | $0.00 | -73.3K | 0 | -100% | $0 |
| DT | 2026-02-17 | 2026-02-13 | MCD | Kempczinski Christopher J | COB, CEO, Dir | A - Grant | $0.00 | +144.4K | 144.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-12 | S | D | 26,277 | $331.35 | 22,900.14 | D | — | — | (F1) This transaction was executed in multiple trades ranging from $330.00 to $332.29 per share. The price reported represents the weighted average sale price of this trade. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price. |
| 2 | Common | Common Stock | 2026-02-13 | F | D | 9,182.50 | $327.58 | 34,445.64 | D | — | — | |
| 3 | Common | Common Stock | 2026-02-13 | M | A | 1,395 | $0.00 | 43,628.14 | D | — | — | (F5) Settlement of dividend equivalent rights in connection with vested RSUs. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock. |
| 4 | Common | Common Stock | 2026-02-13 | M | A | 19,333 | $0.00 | 42,233.14 | D | — | — | (F3) As a result of McDonald's Corporation's (the "Company") performance against the pre-approved financial targets for the performance period of January 1, 2023 through December 31, 2025, the reporting person vested in 82.2% of the original grant of 23,519 performance-based restricted stock units ("RSUs"). (F4) Each performance-based RSU represents a right to acquire one share of the Company's common stock. |
| 5 | Common | Common Stock | 2026-02-13 | S | D | 26,276 | $333.54 | 22,900.14 | D | — | — | (F2) This transaction was executed in multiple trades ranging from $332.50 to $335.22 per share. The price reported represents the weighted average sale price of this trade. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price. |
| 6 | Common | Common Stock | 2026-02-13 | M | A | 26,276 | $128.09 | 49,176.14 | D | — | — | |
| 7 | Common | Common Stock | 2026-02-12 | M | A | 26,277 | $128.09 | 49,177.14 | D | — | — | |
| 8 | Derivative | Options (Right to Buy) | 2026-02-13 | M | D | 26,276 | $0.00 | 0 | D | $128.09 · — to 2027-03-08 | 26,276 Common Stock | (F6) Options were granted on March 8, 2017 and became exercisable in 25% increments on the first, second, third and fourth anniversary of the grant. |
| 9 | Derivative | Restricted Stock Units | 2026-02-13 | M | D | 19,333 | $0.00 | 0 | D | — · 2026-02-13 to 2026-02-13 | 19,333 Common Stock | (F3) As a result of McDonald's Corporation's (the "Company") performance against the pre-approved financial targets for the performance period of January 1, 2023 through December 31, 2025, the reporting person vested in 82.2% of the original grant of 23,519 performance-based restricted stock units ("RSUs"). (F4) Each performance-based RSU represents a right to acquire one share of the Company's common stock. |
| 10 | Derivative | Options (Right to Buy) | 2026-02-12 | M | D | 26,277 | $0.00 | 26,276 | D | $128.09 · — to 2027-03-08 | 26,277 Common Stock | (F6) Options were granted on March 8, 2017 and became exercisable in 25% increments on the first, second, third and fourth anniversary of the grant. |
| 11 | Derivative | Dividend Equivalent Rights | 2026-02-13 | M | D | 1,395 | $0.00 | 0 | D | — · 2026-02-13 to 2026-02-13 | 1,395 Common Stock | (F5) Settlement of dividend equivalent rights in connection with vested RSUs. Each dividend equivalent right is the economic equivalent of one share of the Company's common stock. |
| 12 | Derivative | Options (Right to Buy) | 2026-02-13 | A | A | 144,416 | $0.00 | 144,416 | D | $327.58 · — to 2036-02-13 | 144,416 Common Stock | (F7) Options become exercisable in 25% increments on the first, second, third and fourth anniversary dates of the grant. |